Uncertainties in the Absence of Data: Use of Pravastatin in Young Children
Department of Pediatrics
Pravastatin; Child; Informed Consent; Disclosure
Cardiology | Pediatrics | Preventive Medicine
Learning Objective: Understand that, when risks and benefits of prevention are not fully known, physicians must provide patient decision makers with existing information such as the Number Needed to Treat and the Number Needed to Harm and leave the decision to those whom the intervention will affect.
Shifrin A, Sanghavi D. Uncertainties in the Absence of Data: Use of Pravastatin in Young Children. Virtual Mentor. 2008; 10(11):747-749. Link to article on publisher's website
Shifrin A, Sanghavi DM. (2008). Uncertainties in the Absence of Data: Use of Pravastatin in Young Children. Cardiology. Retrieved from https://escholarship.umassmed.edu/peds_cardiology/19